Endonovo Therapeutics, Inc.
ENDV · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,797 | $6,925 | -$18,475 | -$3,105 |
| Dep. & Amort. | $619 | $647 | $647 | $648 |
| Deferred Tax | $0 | $0 | $0 | -$95 |
| Stock-Based Comp. | $0 | $687 | $45 | $95 |
| Change in WC | $2,279 | $1,708 | $2,009 | $1,223 |
| Other Non-Cash | $0 | -$9,845 | $15,095 | $247 |
| Operating Cash Flow | $100 | $122 | -$679 | -$987 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$203 | -$121 | $465 | $950 |
| Stock Issued | $98 | $11 | $142 | $126 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$10 | -$14 | -$17 |
| Financing Cash Flow | -$105 | -$120 | $593 | $1,059 |
| Forex Effect | $3 | $0 | $0 | $0 |
| Net Chg. in Cash | -$2 | $2 | -$86 | $73 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2 | $0 | $86 | $13 |
| End Cash | $0 | $2 | $0 | $86 |
| Free Cash Flow | $100 | $122 | -$679 | -$987 |